The DePuy Articular Surface Replacement Hip Implant is a hip replacement cup manufactured by DePuy, a division of Johnson & Johnson.  DePuy Orthopaedics withdrew the hip device after more than two years of reports that the hip implant, called an ASR, failed in patients only a few years after implant.  This failure required costly and painful replacement operations. 

The device was first used in the United States in 2005.

Withdrawn from the Australian Market in December 2009, it is under scrutiny in the U.S. and has been withdrawn from the domestic market.

The FDA has received, beginning in 2008, about 300 complaints about the early failure of the implanted device.

On March 9, 2010, DePuy announced that the DePuy ASR Hip Replacement would be discontinued in the U.S. market because it was failing and requiring remedial surgeries.

The same release mentions a higher failure rate in smaller-boned patients and those with certain bone weaknesses.

There is no FDA recall at this time.  Please check back at this website for updates from time to time.

The ASR hip cup is a metal-on-metal ball and socket, large diameter hip resurfacing device.

The cause of the DePuy ASR Cup hip implant failures is still not known. 
Metal debris early in the life of this implant can cause inflammation, leading to damaged muscles and soft tissue.

Among the primary and most serious side-effects mentioned in the ASR hip cup revision reports:

>Implanted cup loosening or failing to bond
>Pseudotumour: a soft tissue mass that may be the result of a toxic reaction to an excess of particulate metal wear debris.
>ALVAL (Aseptic Lymphocyte Dominated Vasculitis Associated Lesion): an adverse tissue reaction to metal particles and ions.
>Metallosis: condition of excessive metal debris.

If you or a loved one has been seriously injured after surgical implantation of a DePuy Acetabular Cup, please contact us immediately for a free consultation as soon as possible.

Leave a Reply